MeSH
Antineoplastic Agents /pharmacology /therapeutic use; Biomarkers, Tumor /antagonists & Carcinoma, Non-Small-Cell Lung /drug therapy /economics /enzymology; Cost-Benefit Analysis; Drug Resistance, Neoplasm; Humans; Lung Neoplasms /drug therapy /economics /enzymology; Models, Biological; Molecular Targeted Therapy /economics; Precision Medicine /economics; Pyrazoles /pharmacology /therapeutic use; Pyridines /pharmacology /therapeutic use; Quality of Life; Receptor Protein-Tyrosine Kinases /antagonists & inhibitors /metabolism; inhibitors /metabolism